Diagnostic Value of Cytology in Detecting Endometrial Hyperplasia and Endometrial and Ovarian Cancers in Patients Undergoing Hysterectomy or Salpingo-Oophorectomy
- PMID: 31016178
- PMCID: PMC6446583
- DOI: 10.4103/abr.abr_191_18
Diagnostic Value of Cytology in Detecting Endometrial Hyperplasia and Endometrial and Ovarian Cancers in Patients Undergoing Hysterectomy or Salpingo-Oophorectomy
Abstract
Background: Ovarian cancer (OC) is one of the most common cancers among women in the world. This study aimed to compare the results of endometrial and endocervical cytology with the ultimate outcome of the uterus, ovary, and fallopian tube (derived from hysterectomy or salpingo-oophorectomy) in diagnosing endometrial hyperplasia, endometrial, and OC.
Materials and methods: This cross-sectional study was conducted on 30 women with endometrial hyperplasia, 90 cases of endometrial cancer, 30 cases of OC, and 30 normal controls undergoing hysterectomy or salpingo-oophorectomy referring to Al-Zahra and Shahid Beheshti Hospitals in 2015-2017. Their basic and clinical characteristics were recorded, and then, endometrial cytology was performed by a specialist and sent to a pathological center.
Results: Diagnostic value of cytology showed that out of 90 individuals with endometrial cancer, 78 (86.7%) ones were positive and 12 (13.3%) were negative with sensitivity and specificity of 86.67% and 100%, respectively. Its positive predictive values (PPVs) and negative predictive values (NPVs) were 100% and 71.4% (AUC = 0.933; P < 0.0001). In diagnosing endometrial hyperplasia out of 30 individuals with endometrial hyperplasia, there were 24 (80.0%) positive and 6 (20.0%) negative with sensitivity and specificity of 80.00% and 100%, respectively. Its PPVs and NPVs were 100% and 83.3%, respectively (AUC = 0.9000; P < 0.0001). In diagnosing, OC cytology could not detect any one of the 30 individuals with OC, with sensitivity and specificity of 0% and 100.0%, respectively. Its PPVs and NPVs were 0% and 50%, respectively (AUC = 0.500; P = 1.00).
Conclusion: Cytology has a good diagnostic value for detecting endometrial hyperplasia and endometrial cancer compared to pathology; however, due to very low sensitivity in detection of OC, it could not be considered as a good diagnostic tool.
Keywords: Cytology; diagnostic value; endometrial cancer; hyperplasia; hysterectomy; ovarian cancers; salpingo-oophorectomy.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Transvaginal ultrasound, endometrial cytology sampled by Gynoscann and histology obtained by Uterine Explora Curette compared to the histology of the uterine specimen. A prospective study in pre- and postmenopausal women undergoing elective hysterectomy.Acta Obstet Gynecol Scand. 1997 Sep;76(8):790-6. doi: 10.3109/00016349709024349. Acta Obstet Gynecol Scand. 1997. PMID: 9348260
-
Vaginal hysterectomy with or without bilateral salpingo-oophorectomy may be an alternative treatment for endometrial cancer patients with medical co-morbidities precluding standard surgical procedures: a systematic review.Int J Gynecol Cancer. 2019 Feb;29(2):299-304. doi: 10.1136/ijgc-2018-000015. Epub 2019 Jan 18. Int J Gynecol Cancer. 2019. PMID: 30659027
-
Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer.BJOG. 2003 Jul;110(7):690-5. BJOG. 2003. PMID: 12842061
-
Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature.Int J Gynecol Pathol. 2020 Jul;39(4):313-320. doi: 10.1097/PGP.0000000000000643. Int J Gynecol Pathol. 2020. PMID: 31851061 Review.
-
The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.BMC Cancer. 2016 Jan 14;16:18. doi: 10.1186/s12885-015-2011-5. BMC Cancer. 2016. PMID: 26768420 Free PMC article. Review.
References
-
- Chambers SK, Hess LM. Fundamentals of Cancer Prevention. Switzerland: Springer, Berlin, Heidelberg; 2014. Ovarian cancer prevention; pp. 557–91.
-
- Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol. 2006;100:20–6. - PubMed
-
- Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384:1376–88. - PubMed
-
- Ferenczy A, Gelfand MM. Outpatient endometrial sampling with endocyte: Comparative study of its effectiveness with endometrial biopsy. Obstet Gynecol. 1984;63:295–302. - PubMed